SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
29 hedge funds and large institutions have $1.55M invested in Seelos Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
29
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
1 | +$188K | |
2 | +$166K | |
3 | +$141K | |
4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$67.7K |
5 |
MWM
Modera Wealth Management
Westwood,
New Jersey
|
+$51.9K |
Top Sellers
1 | -$422K | |
2 | -$56.3K | |
3 | -$55.6K | |
4 |
Morgan Stanley
New York
|
-$8.4K |
5 |
Two Sigma Investments
New York
|
-$7.2K |